Law and Policies Effect on EPA Work Plans and Non-Animal Vertebrate Timeline
By Andrea Uhlig | October 12, 2023
Government agencies, such as the Environmental Protection Agency (EPA), make regulatory decisions based on laws set by Congress, and policies put in place by past or current administrations…
ARPA-H: A Catalyst for Advancing Microphysiological Systems
By Yiguang Zhu | September 28, 2023
The Advanced Research Projects Agency for Health (ARPA-H), a new federal agency within the NIH, has emerged as a significant force in biomedical and health research…
The Shortage of Non-Human Primates Available for Research Opens a Door for Non-Animal Test Methods
By Sherman McFarland | September 14, 2023
Federal agencies and elected officials should not view the shortage of non-human primates (NHP) available for research as a problem that needs to be fixed by acquiring more NHPs. The real problem is what the NHP shortage allegedly does: impedes research…
Where Do MoCRA and HCA Fall in the Landscape of Animal Cosmetics Testing?
By Breanne Kincaid | August 31, 2023
From drug stores to department store cosmetic aisles, flashy labels highlighting that products are “cruelty free” or “not tested on animals” abound. It’s clear that consumer sentiment is driving substantial change in animal testing practices, and state and federal governments appear to be getting on board…
FDA Modernization Act 2.0 – An Important Step in the Right Direction, but Much Work Remains
By Rebecca Critser | August 9, 2023
In December 2022, Congress passed the FDA Modernization Act 2.0 and President Biden signed it into law as part of the Omnibus bill. This new law has implications for the future use of alternatives to animal models in science and research…